Asymmetry of pathology in Alzheimer's disease.

Asymmetry of pathology in Alzheimer's disease.

Détails bibliographiques
Auteurs principaux:	Wilcock, G, Esiri, M
Format:	Journal article
Langue:	English
Publié:	BMJ Publishing Group 1987

Documents similaires

Pathologic diagnosis of Alzheimer's.
par: Köster, R, et autres
Publié: (1989)

Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease.
par: Pearson, R, et autres
Publié: (1985)

Age and Alzheimer's disease.
par: Wilcock, G, et autres
Publié: (1983)

The olfactory bulbs in Alzheimer's disease.
par: Esiri, M, et autres
Publié: (1984)

Coexisting pathologies in the brain: influence of vascular disease and Parkinson's disease on Alzheimer's pathology in the hippocampus.
par: Smith, M, et autres
Publié: (2000)

Loss of perineuronal nets in Alzheimer's disease is not related to tau pathology
par: Baig, S, et autres
Publié: (2004)

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
par: Williams, S, et autres
Publié: (2005)

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease
par: Williams, S, et autres
Publié: (2005)

Decreased CSF acetylcholinesterase activity in Alzheimer's disease.
par: Appleyard, M, et autres
Publié: (1983)

Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease.
par: Chapel, H, et autres
Publié: (1984)

Vulnerability to Alzheimer's pathology in neocortex: The roles of plasticity and columnar organization
par: Esiri, M, et autres
Publié: (2006)

Vulnerability to Alzheimer's pathology in neocortex: the roles of plasticity and columnar organization.
par: Esiri, M, et autres
Publié: (2006)

Vulnerability to Alzheimer's pathology in neocortex: The roles of plasticity and columnar organization
par: Esiri, M, et autres
Publié: (2006)

Constructional apraxia in Alzheimer's disease: association with occipital lobe pathology and accelerated cognitive decline.
par: Smith, M, et autres
Publié: (2001)

Cerebral subcortical small vessel disease in subjects with pathologically confirmed alzheimer disease: A clinicopathologic study in the oxford project to investigate memory and ageing (OPTIMA)
par: Esiri, M, et autres
Publié: (2014)

Cerebral subcortical small vessel disease in subjects with pathologically confirmed Alzheimer disease: a clinicopathologic study in the Oxford Project to Investigate Memory and Ageing (OPTIMA).
par: Esiri, M, et autres
Publié: (2014)

Treatment for Alzheimer's disease.
par: Wilcock, G
Publié: (2000)

Neurotrophins in Alzheimer's disease
par: Wilcock, G
Publié: (2002)

Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease.
par: Minger, S, et autres
Publié: (2001)

SOME OBSERVATIONS ON THE DISTRIBUTION OF CORTICAL TANGLES IN ALZHEIMERS-DISEASE
par: Esiri, M, et autres
Publié: (1985)

The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry.
par: Wilcock, G, et autres
Publié: (1983)

Galantamine in Alzheimer's disease.
par: Razay, G, et autres
Publié: (2008)

Hyperinsulinaemia and Alzheimer's disease.
par: Razay, G, et autres
Publié: (1994)

Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
par: Palmer, A, et autres
Publié: (1987)

Treating Alzheimer's disease.
par: Wilcock, G, et autres
Publié: (1995)

Velnacrine for Alzheimer's disease.
par: Birks, J, et autres
Publié: (2004)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
par: Wilcock, G
Publié: (1990)

Alzheimer's disease--current issues.
par: Wilcock, G
Publié: (1988)

Blood-based proteomic biomarkers of Alzheimer’s disease pathology
par: Baird, A, et autres
Publié: (2015)

The effects of cell cycle progression and Alzheimer-type pathology on cognitive decline
par: Smith, M, et autres
Publié: (2000)

Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
par: Pearce, B, et autres
Publié: (1984)

Non-immunoglobin in cerebrospinal fluid of patients with Alzheimer's disease and cerebral amyloid angiopathy.
par: Esiri, M, et autres
Publié: (1985)

The increasing burden of Alzheimer disease.
par: Sadik, K, et autres
Publié: (2003)

Current approaches to the treatment of Alzheimer's disease.
par: Wilcock, G
Publié: (1996)

Treatment of the cholinergic impairment in Alzheimer's disease
par: Wilcock, G
Publié: (1994)

Bapineuzumab in Alzheimer's disease: where now?
par: Wilcock, G
Publié: (2010)

APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
par: Chalmers, K, et autres
Publié: (2003)

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
par: Wilcock, G, et autres
Publié: (1982)

THE RELATIONSHIP OF ARGYROPHILIC PLAQUES AND NEUROFIBRILLARY TANGLES TO THE SEVERITY OF DEMENTIA AND CORTICAL CHOLINE ACETYL TRANSFERASE LEVELS IN ALZHEIMERS-DISEASE
par: Wilcock, G, et autres
Publié: (1983)

Modelling cerebrovascular pathology and the spread of amyloid beta in Alzheimer’s disease
par: Ahern, A, et autres
Publié: (2025)